Stephens Inc. AR Has $206,000 Holdings in Neogen Corporation (NASDAQ:NEOG)

Stephens Inc. AR trimmed its position in Neogen Corporation (NASDAQ:NEOG) by 21.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,809 shares of the company’s stock after selling 6,663 shares during the period. Stephens Inc. AR’s holdings in Neogen were worth $206,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Covestor Ltd raised its position in shares of Neogen by 41.4% in the 4th quarter. Covestor Ltd now owns 4,103 shares of the company’s stock valued at $50,000 after acquiring an additional 1,202 shares during the period. CHICAGO TRUST Co NA increased its stake in Neogen by 19.1% during the 1st quarter. CHICAGO TRUST Co NA now owns 12,498 shares of the company’s stock worth $108,000 after purchasing an additional 2,000 shares in the last quarter. Ascent Group LLC increased its stake in Neogen by 17.8% during the 4th quarter. Ascent Group LLC now owns 14,340 shares of the company’s stock worth $174,000 after purchasing an additional 2,165 shares in the last quarter. Harbour Investments Inc. bought a new stake in Neogen during the 4th quarter worth approximately $27,000. Finally, Commonwealth Equity Services LLC increased its stake in Neogen by 6.1% during the 4th quarter. Commonwealth Equity Services LLC now owns 39,263 shares of the company’s stock worth $477,000 after purchasing an additional 2,267 shares in the last quarter. 96.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Neogen

In related news, Director Aashima Gupta purchased 16,000 shares of the company’s stock in a transaction that occurred on Monday, May 12th. The stock was acquired at an average price of $6.25 per share, with a total value of $100,000.00. Following the completion of the purchase, the director directly owned 21,917 shares in the company, valued at $136,981.25. This trade represents a 270.41% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director James P. Tobin purchased 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 22nd. The stock was bought at an average cost of $4.73 per share, with a total value of $47,300.00. Following the purchase, the director owned 37,474 shares of the company’s stock, valued at $177,252.02. This represents a 36.40% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 73,500 shares of company stock worth $380,825 over the last ninety days. Corporate insiders own 1.13% of the company’s stock.

Neogen Price Performance

NASDAQ:NEOG opened at $4.74 on Monday. Neogen Corporation has a 1-year low of $3.87 and a 1-year high of $18.58. The company has a current ratio of 3.91, a quick ratio of 2.45 and a debt-to-equity ratio of 0.33. The firm has a fifty day simple moving average of $5.52 and a 200 day simple moving average of $7.74. The stock has a market capitalization of $1.03 billion, a PE ratio of -2.13 and a beta of 1.77.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on NEOG shares. Guggenheim decreased their price target on shares of Neogen from $13.00 to $10.00 and set a “buy” rating for the company in a research note on Monday, June 30th. Piper Sandler decreased their target price on shares of Neogen from $6.40 to $5.00 and set a “neutral” rating for the company in a research note on Tuesday, April 22nd.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.